找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Hepatocellular Carcinoma; Diagnosis and Treatm Brian I. Carr Book 2016Latest edition Springer International Publishing Switzerland 2016 gas

[复制链接]
查看: 43530|回复: 64
发表于 2025-3-21 19:04:19 | 显示全部楼层 |阅读模式
书目名称Hepatocellular Carcinoma
副标题Diagnosis and Treatm
编辑Brian I. Carr
视频video
概述Provides the reader with a clear understanding of the many mechanisms involved in carcinogenesis of the liver.Comprehensive and detailed review of how to diagnose and treat hepatocellular carcinoma.Wr
丛书名称Current Clinical Oncology
图书封面Titlebook: Hepatocellular Carcinoma; Diagnosis and Treatm Brian I. Carr Book 2016Latest edition Springer International Publishing Switzerland 2016 gas
描述• Hepatocellular carcinoma (HCC) used to be regarded as a rare disease. However, the increasing numbers of chronic HCC carriers in the U.S. and subsequent increased incidences of HCC seen in most large medical centers means that it is no longer an uncommon disease for gastroenterologists or oncologists to encounter and its incidence and epidemiology are changing. During this exciting time in the field of HCC basic science and clinical management, many changes are simultaneously occurring at multiple levels of our understanding and management of the disease. Suddenly, there are several new choices of therapy to offer patients. Hepatocellular Carcinoma, 3rd edition addresses this fast-changing disease and gives the reader a clearer understanding of the many mechanisms involved in carcinogenesis of the liver. This comprehensive and detailed review of how to diagnose and treat hepatocellular carcinoma is written by international leaders in the field, covering both clinical treatment choices and the basic science underlying HCC development. Updated and enhanced from the last edition in 2009, Hepatocellular Carcinoma, 3rd edition features 12 new chapters including discussion of molecular
出版日期Book 2016Latest edition
关键词gastroenterology; hepatocellucal carcinoma; oncology; surgical oncology; hepatology
版次3
doihttps://doi.org/10.1007/978-3-319-34214-6
isbn_softcover978-3-319-81705-7
isbn_ebook978-3-319-34214-6Series ISSN 2364-1134 Series E-ISSN 2364-1142
issn_series 2364-1134
copyrightSpringer International Publishing Switzerland 2016
The information of publication is updating

书目名称Hepatocellular Carcinoma影响因子(影响力)




书目名称Hepatocellular Carcinoma影响因子(影响力)学科排名




书目名称Hepatocellular Carcinoma网络公开度




书目名称Hepatocellular Carcinoma网络公开度学科排名




书目名称Hepatocellular Carcinoma被引频次




书目名称Hepatocellular Carcinoma被引频次学科排名




书目名称Hepatocellular Carcinoma年度引用




书目名称Hepatocellular Carcinoma年度引用学科排名




书目名称Hepatocellular Carcinoma读者反馈




书目名称Hepatocellular Carcinoma读者反馈学科排名




单选投票, 共有 1 人参与投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 23:52:39 | 显示全部楼层
发表于 2025-3-22 04:17:26 | 显示全部楼层
Chemically-Induced Hepatocarcinogenesisinogen exposure, are believed to contribute to its distinct geographical distribution pattern [.]. Although rare genetic disorders can contribute to liver cancer development, ethanol, smoking and dietary factors are known to contribute to its incidence and progression [., .]. The prevalence of liver
发表于 2025-3-22 05:43:50 | 显示全部楼层
发表于 2025-3-22 09:28:59 | 显示全部楼层
Role of the Immune System in Hepatocellular Carcinoma: Implications for Existing and Novel Therapies and may thus represent a common pathway of hepatocarcinogenesis. In this chapter, we will summarize our current understanding of the dual role of the immune system in the development and control of HCC. We will furthermore discuss implications of these findings for existing and novel therapies.
发表于 2025-3-22 15:33:20 | 显示全部楼层
发表于 2025-3-22 19:36:52 | 显示全部楼层
Hepatocellular Carcinoma Associated with Hepatitis B Virusffective and safe vaccine for HBV is available. Currently, over 180 counties have adopted a universal vaccination program to all newborn infants, a policy that is already impacting the prevalence of HBV-related HCC in children and adolescents. Secondary prevention of HCC focuses on the 350–400 milli
发表于 2025-3-23 00:19:28 | 显示全部楼层
Hepatitis C and Hepatocellular Carcinoma both tumor stage and liver function. Effective treatments for HCC include percutaneous ablation, surgical resection, and liver transplantation. Both percutaneous ablation and surgical resection provide a high rate of complete responses and are assumed to improve survival that should exceed 50 % at
发表于 2025-3-23 05:10:43 | 显示全部楼层
发表于 2025-3-23 07:04:46 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-15 02:03
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表